Characterization and Therapeutic Use of Extracellular Vesicles Derived from Platelets

Area of Science:

• Regenerative Medicine
• Cell Biology
• Biotechnology

Background:

• Platelet-rich plasma (PRP) is utilized in regenerative medicine, but its mechanisms are not fully understood.
• Plasma contains extracellular vesicles (EVs), with platelet-derived EVs (PL-EVs) being the most prevalent.
• PL-EVs are increasingly recognized for their therapeutic potential due to inherent advantages.

Purpose of the Study:

• To review the biological characteristics and isolation methods of platelet-derived EVs (PL-EVs).
• To discuss the role of PL-EVs in disease pathology.
• To highlight the therapeutic and regenerative applications of PL-EVs.

Main Methods:

• Literature review focusing on platelet-derived EVs (PL-EVs) and their applications.
• Analysis of existing research on PL-EV isolation and characterization.
• Synthesis of evidence regarding PL-EVs in disease and therapy.

Main Results:

• Platelet-derived EVs (PL-EVs), including exosomes, are key components of PRP.
• PL-EVs possess advantageous properties like low immunogenicity and ease of isolation.
• PL-EVs demonstrate potential in modulating disease pathology and promoting tissue repair.

Conclusions:

• Platelet-derived EVs (PL-EVs) represent a promising cell-free therapeutic tool.
• Further research into PL-EVs can advance regenerative medicine and disease treatment.
• Understanding PL-EVs is crucial for harnessing their full medical potential.